IL1B and type 2 diabetes mellitus: For instance, Shao et al., 2020, reported a reduction in plasmatic levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and an increase in adiponectin (which belongs to the anti-inflammatory adipokines) in T2DM patients [48].